Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostamatinib Monotherapy vs Adalimumab in Rheumatoid Arthritis (OSKIRA-4)
NCT01264770Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Jan 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of fostamatinib in rheumatoid arthritis (RA), sponsored by AstraZeneca. Started Jan 2011; status: terminated.
02
Drugs
fostamatinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01264770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01264770.